Benzinga | Nov 5, 2020 04:09PM EST

Deciphera Pharmaceuticals Q3 EPS $(1.13) Beats $(1.30) Estimate, Sales $15.45M Beat $7.05M Estimate

Deciphera Pharmaceuticals (NASDAQ:DCPH) reported quarterly losses of $(1.13) per share which beat the analyst consensus estimate of $(1.30) by 13.08 percent. This is a 11.72 percent increase over losses of $(1.28) per share from the same period last year. The company reported quarterly sales of $15.45 million which beat the analyst consensus estimate of $7.05 million by 119.13 percent.